Oakworth Capital’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45K | Sell |
30
-144
| -83% | -$6.96K | ﹤0.01% | 583 |
|
|
2025
Q1 | $9.65K | Buy |
174
+144
| +480% | +$7.99K | ﹤0.01% | 519 |
|
|
2024
Q4 | $1.45K | Hold |
30
| – | – | ﹤0.01% | 586 |
|
|
2024
Q3 | $1.73K | Hold |
30
| – | – | ﹤0.01% | 618 |
|
|
2024
Q2 | $1.46K | Hold |
30
| – | – | ﹤0.01% | 683 |
|
|
2024
Q1 | $1.46K | Buy |
+30
| New | +$1.46K | ﹤0.01% | 649 |
|
|
2022
Q3 | – | Sell |
-430
| Closed | -$22K | – | 574 |
|
|
2022
Q2 | $22K | Sell |
430
-20
| -4% | -$1.02K | ﹤0.01% | 376 |
|
|
2022
Q1 | $23K | Sell |
450
-100
| -18% | -$5.11K | ﹤0.01% | 372 |
|
|
2021
Q4 | $28K | Sell |
550
-104
| -16% | -$5.3K | ﹤0.01% | 388 |
|
|
2021
Q3 | $32K | Hold |
654
| – | – | ﹤0.01% | 358 |
|
|
2021
Q2 | $34K | Hold |
654
| – | – | ﹤0.01% | 356 |
|
|
2021
Q1 | $32K | Buy |
+654
| New | +$32K | ﹤0.01% | 354 |
|
|
2018
Q1 | – | Sell |
-887
| Closed | -$40K | – | 644 |
|
|
2017
Q4 | $40K | Hold |
887
| – | – | 0.01% | 307 |
|
|
2017
Q3 | $43K | Hold |
887
| – | – | 0.01% | 311 |
|
|
2017
Q2 | $42K | Hold |
887
| – | – | 0.01% | 307 |
|
|
2017
Q1 | $40K | Hold |
887
| – | – | 0.01% | 302 |
|
|
2016
Q4 | $36K | Sell |
887
-140
| -14% | -$5.68K | 0.01% | 299 |
|
|
2016
Q3 | $39K | Sell |
1,027
-124
| -11% | -$4.71K | 0.01% | 284 |
|
|
2016
Q2 | $47K | Buy |
1,151
+271
| +31% | +$11.1K | 0.02% | 259 |
|
|
2016
Q1 | $35K | Hold |
880
| – | – | 0.01% | 246 |
|
|
2015
Q4 | $38K | Hold |
880
| – | – | 0.02% | 217 |
|
|
2015
Q3 | $42K | Hold |
880
| – | – | 0.02% | 170 |
|
|
2015
Q2 | $48K | Hold |
880
| – | – | 0.02% | 164 |
|
|
2015
Q1 | $44K | Hold |
880
| – | – | 0.02% | 197 |
|
|
2014
Q4 | $40K | Hold |
880
| – | – | 0.02% | 197 |
|
|
2014
Q3 | $48K | Hold |
880
| – | – | 0.03% | 139 |
|
|
2014
Q2 | $47K | Hold |
880
| – | – | 0.03% | 140 |
|
|
2014
Q1 | $46K | Buy |
880
+616
| +233% | +$32.2K | 0.03% | 139 |
|
|
2013
Q4 | $14K | Buy |
+264
| New | +$14K | 0.01% | 240 |
|